Hearings to examine the Consumer Financial Protection Bureau's Semi-Annual Report to Congress, including S.954, to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals.